U.S. FDA approves first mRNA flu shot from Moderna
The approval was based on data from a late-stage trial involving more than 40,000 adults aged 50 and older, which showed the shot was 26.6% more effective than a licensed standard-dose flu vaccine | Photo Credit: Reuters The U.S. Food and Drug Administration has approved Moderna’s flu vaccine for people aged 50 and older, the…
Read More “U.S. FDA approves first mRNA flu shot from Moderna” »
